TMCITreace Medical Concepts, Inc.

$104M

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$30M+45.1% YoY

Gross Profit

$25M82.3% margin

Operating Income

-$12M-39.8% margin

Net Income

-$17M-57.5% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+3.2%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$16M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$159M

Total Liabilities

$87M

Stockholders' Equity

$72M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$21M	+45.1%
Gross Profit	$25M	$17M	+47.7%
Operating Income	-$12M	-$4M	-194.6%
Net Income	-$17M	-$5M	-239.1%

TMCI Q2 2022 Earnings — Treace Medical Concepts, Inc. Revenue & Financial Results | Market Cap Arena